lsa
Treatment for Cluster Headache
Lysergic acid amide (LSA) acts as a partial agonist at serotonin 5-HT2A receptors, which may modulate neurotransmitter release and neural connectivity associated with cluster headache pathophysiology. Its potential therapeutic effects include vasoactive and neurogenic mechanisms that can interrupt or reduce the frequency and intensity of cluster headache episodes through central nervous system modulation.